Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Ullman

Showing results (21-30 of 28) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 28 results.
Bioorganic & Medicinal Chemistry Letters|September 25, 2003
Structure-activity relationships within a series of caspase inhibitors: effect of leaving group modificationsBrett R Ullman, Teresa Aja, Thomas L Deckwerth, et al.
Biorxiv : the Preprint Server for Biology|March 10, 2025
Rapaprotin is Activated by an Endopeptidase to Disassemble 26S ProteasomeHanjing Peng, Zufeng Guo, Wei Li Wang, et al.
Bioorganic & Medicinal Chemistry Letters|September 25, 2002
Acyl dipeptides as reversible caspase inhibitors. Part 2: further optimizationSteven D Linton, Donald S Karanewsky, Robert J Ternansky, et al.
Angewandte Chemie (International Ed. in English)|September 17, 2025
Rapaprotin, an Endopeptidase-Activated Proteasome Inhibitor that Induces 26S DisassemblyHanjing Peng, Zufeng Guo, Wei Li Wang, et al.
Bioorganic & Medicinal Chemistry Letters|June 21, 2005
Structure-activity relationships within a series of caspase inhibitors. Part 2: Heterocyclic warheadsBrett R Ullman, Teresa Aja, Ning Chen, et al.
Bioorganic & Medicinal Chemistry Letters|April 28, 2004
Oxamyl dipeptide caspase inhibitors developed for the treatment of strokeSteven D Linton, Teresa Aja, Peter R Allegrini, et al.
The New England Journal of Medicine|February 8, 2013
Topical paromomycin with or without gentamicin for cutaneous leishmaniasisAfif Ben Salah, Nathalie Ben Messaoud, Evelyn Guedri, et al.
Journal of Medicinal Chemistry|October 28, 2005
First-in-class pan caspase inhibitor developed for the treatment of liver diseaseSteven D Linton, Teresa Aja, Robert A Armstrong, et al.
Pageof 3

Showing results (21-30 of 28) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 28 results.
Bioorganic & Medicinal Chemistry Letters|September 25, 2003
Structure-activity relationships within a series of caspase inhibitors: effect of leaving group modificationsBrett R Ullman, Teresa Aja, Thomas L Deckwerth, et al.
Biorxiv : the Preprint Server for Biology|March 10, 2025
Rapaprotin is Activated by an Endopeptidase to Disassemble 26S ProteasomeHanjing Peng, Zufeng Guo, Wei Li Wang, et al.
Bioorganic & Medicinal Chemistry Letters|September 25, 2002
Acyl dipeptides as reversible caspase inhibitors. Part 2: further optimizationSteven D Linton, Donald S Karanewsky, Robert J Ternansky, et al.
Angewandte Chemie (International Ed. in English)|September 17, 2025
Rapaprotin, an Endopeptidase-Activated Proteasome Inhibitor that Induces 26S DisassemblyHanjing Peng, Zufeng Guo, Wei Li Wang, et al.
Bioorganic & Medicinal Chemistry Letters|June 21, 2005
Structure-activity relationships within a series of caspase inhibitors. Part 2: Heterocyclic warheadsBrett R Ullman, Teresa Aja, Ning Chen, et al.
Bioorganic & Medicinal Chemistry Letters|April 28, 2004
Oxamyl dipeptide caspase inhibitors developed for the treatment of strokeSteven D Linton, Teresa Aja, Peter R Allegrini, et al.
The New England Journal of Medicine|February 8, 2013
Topical paromomycin with or without gentamicin for cutaneous leishmaniasisAfif Ben Salah, Nathalie Ben Messaoud, Evelyn Guedri, et al.
Journal of Medicinal Chemistry|October 28, 2005
First-in-class pan caspase inhibitor developed for the treatment of liver diseaseSteven D Linton, Teresa Aja, Robert A Armstrong, et al.
Pageof 3